|
1
|
Fukushima T, Tezuka T, Shimomura T, Nakano
S and Kataoka H: Silencing of insulin-like growth factor-binding
protein-2 in human glioblastoma cells reduces both invasiveness and
expression of progression-associated gene CD24. J Biol Chem.
282:18634–18644. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai A, Tran A, Nghiemphu PL, Pope WB,
Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, et al:
Phase II study of bevacizumab plus temozolomide during and after
radiation therapy for patients with newly diagnosed glioblastoma
multiforme. J Clin Oncol. 29:142–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zinovieva RD, Duncan MK, Johnson TR,
Torres R, Polymeropoulos MH and Tomarev SI: Structure and
chromosomal localization of the human homeobox gene Prox 1.
Genomics. 35:517–522. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim H, Cruz M, Bourdeau A and Dumont DJ:
Cell-cell interactions influence vascular reprogramming by Prox1
during embryonic development. PLoS One. 8:e521972013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sosa-Pineda B, Wigle JT and Oliver G:
Hepatocyte migration during liver development requires Prox1. Nat
Genet. 25:254–255. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ragusa S, Cheng J, Ivanov KI, Zangger N,
Ceteci F, Bernier-Latmani J, Milatos S, Joseph JM, Tercier S,
Bouzourene H, et al: PROX1 promotes metabolic adaptation and fuels
outgrowth of Wnt(high) metastatic colon cancer cells. Cell Rep.
8:1957–1973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wiener Z, Högström J, Hyvönen V, Band AM,
Kallio P, Holopainen T, Dufva O, Haglund C, Kruuna O, Oliver G, et
al: Prox1 promotes expansion of the colorectal cancer stem cell
population to fuel tumor growth and ischemia resistance. Cell Rep.
8:1943–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Zhang JB, Qin Y, Wang W, Wei L,
Teng Y, Guo L, Zhang B, Lin Z, Liu J, et al: PROX1 promotes
hepatocellular carcinoma metastasis by way of up-regulating
hypoxia-inducible factor 1α expression and protein stability.
Hepatology. 58:692–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akagami M, Kawada K, Kubo H, Kawada M,
Takahashi M, Kaganoi J, Kato S, Itami A, Shimada Y, Watanabe G and
Sakai Y: Transcriptional factor Prox1 plays an essential role in
the antiproliferative action of interferon-γ in esophageal cancer
cells. Ann Surg Oncol. 18:3868–3877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahashi M, Yoshimoto T, Shimoda M, Kono
T, Koizumi M, Yazumi S, Shimada Y, Doi R, Chiba T and Kubo H: Loss
of function of the candidate tumor suppressor prox1 by RNA mutation
in human cancer cells. Neoplasia. 8:1003–1010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elsir T, Eriksson A, Orrego A, Lindström
MS and Nistér M: Expression of PROX1 is a common feature of
high-grade malignant astrocytic gliomas. J Neuropathol Exp Neurol.
69:129–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elsir T, Qu M, Berntsson SG, Orrego A,
Olofsson T, Lindström MS, Nistér M, von Deimling A, Hartmann C,
Ribom D and Smits A: PROX1 is a predictor of survival for gliomas
WHO grade II. Br J Cancer. 104:1747–1754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cherry EM, Lee DW, Jung JU and Sitcheran
R: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)
promotes glioma cell invasion through induction of NF-κB-inducing
kinase (NIK) and noncanonical NF-κB signaling. Mol Cancer.
14:92015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han S, Xia J, Qin X, Han S and Wu A:
Phosphorylated SATB1 is associated with the progression and
prognosis of glioma. Cell Death Dis. 4:e9012013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siebzehnrubl FA, Silver DJ, Tugertimur B,
Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT,
Kupper MD, Neal D, et al: The ZEB1 pathway links glioblastoma
initiation, invasion and chemoresistance. EMBO Mol Med.
5:1196–1212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu MH, Huang CC, Pan MR, Chen HH and Hung
WC: Prospero homeobox 1 promotes epithelial-mesenchymal transition
in colon cancer cells by inhibiting E-cadherin via miR-9. Clin
Cancer Res. 18:6416–6425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bera A, Ghosh-Choudhury N, Dey N, Das F,
Kasinath BS, Abboud HE and Choudhury GG: NFκB-mediated cyclin D1
expression by microRNA-21 influences renal cancer cell
proliferation. Cell Signal. 25:2575–2586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee GR, Jang SH, Kim CJ, Kim AR, Yoon DJ,
Park NH and Han IS: Capsaicin suppresses the migration of
cholangiocarcinoma cells by down-regulating matrix
metalloproteinase-9 expression via the AMPK-NF-κB signaling
pathway. Clin Exp Metastasis. 31:897–907. 2014. View Article : Google Scholar : PubMed/NCBI
|
